HALEON receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HALEON PLC ADR (HLN)
The HALEON ADR share price today is 9.060, view NYSE HLN stock exchange data. Track the latest HALEON ADR share price with real-time updates on HLN stock performance including market cap, day range, 52-week range and dividend yield. Access HLN charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.970
9.080
52 wk Range
8.380
11.280
HLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.9709.080
52 wk Range
8.38011.280
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HLN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
10.398
Upside
+14.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 4 consecutive years
HALEON receives Investment Bank Analyst Rating Update- Investing.com
Pro
- HALEON receives Investment Bank Analyst Rating Update
- Investing.com
Pro - HALEON receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- HALEON receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 10.398
(+14.77% Upside)
HALEON PLC ADR Earnings Call Summary for Q3/2026
- Haleon Q3 organic sales missed expectations; shares plunged 14.7% premarket to $8.53 amid weakness in North America, China, and Europe.
- North America cold/flu consumption fell high-single digits; China Centrum OTC issue cut group results ~50bps with no near-term resolution expected.
- Full-year profit guidance maintained, supported by supply chain productivity and operating model savings; net leverage at 2.5x enables buybacks.
- Q4 outlook cautious due to competitive pain relief launches and late Advil innovation rollout; Sensodyne growth momentum not expected to sustain.
- Management projects stronger 2027 with enhanced innovation pipeline in oral/digestive health, AI-driven commercial tools, and accelerated emerging market launches.
Last Updated: 29-10-2026, 03:20 pm
Read Full TranscriptEarnings
Latest Release
29-10-2026
EPS / Forecast
0.15 / 0.15
Revenue / Forecast
3.84B / 3.9B
Compare HLN to Peers and Sector
Metrics to compare | HLN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHLNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.3x | 24.8x | −0.2x | |
PEG Ratio | 2.15 | 0.09 | 0.00 | |
Price/Book | 1.8x | 4.1x | 2.6x | |
Price / LTM Sales | 2.7x | 2.5x | 2.8x | |
Upside (Analyst Target) | 14.8% | 12.2% | 60.9% | |
Fair Value Upside | Unlock | 9.9% | 9.5% | Unlock |
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the HALEON ADR (HLN) Share Price Today?
The HALEON ADR share price today is 9.060.
What is the current HALEON ADR (HLN) share price and day range?
As of 11-11-2026, the HALEON ADR share price is 9.060, with a previous close of 9.060. The share price has ranged from 8.970 to 9.080 today, while the 52-week range spans from 8.380 to 11.280.
What Is the HALEON ADR Market Cap?
As of today, HALEON ADR market cap is 39.280B.
Does HALEON ADR Pay Dividends? What's The Current Dividend Yield?
The HALEON ADR dividend yield is 2.1%%.
What Is the HALEON ADR (HLN) Share Price Target?
The average 12-month share price target for HALEON ADR is 10.398, with a high estimate of 11.4 and a low estimate of 9.79. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +14.77% Upside potential.
What Is HALEON ADR's Earnings Per Share (TTM)?
The HALEON ADR EPS (TTM) is 0.24.
When Is the Next HALEON ADR Earnings Date?
HALEON ADR will release its next earnings report on 04-03-2027.
From a Technical Analysis Perspective, Is HLN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does HALEON ADR Trade On?
HALEON ADR is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for HALEON ADR?
The stock symbol for HALEON ADR is "HLN."
How Many Times Has HALEON ADR Stock Split?
HALEON ADR has split 0 times.
How Many Employees Does HALEON ADR Have?
HALEON ADR has 24535 employees.
What Is the HLN Premarket Price?
HLN's last pre-market stock price is 9.040. The pre-market share volume is 430.000, and the stock has changed by -0.020, or -0.220%.
What Is the HLN After Hours Price?
HLN's last after hours stock price is 9.080, the stock has changed by 0.020, or 0.220%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.